September is Sickle Cell Awareness Month. More than 100,000 people in the United States have sickle cell anemia, but 1 out of 15 Black people carry the sickle cell trait. Sickle cell is an inherited ...

Contrary to misconceptions among medical professionals and patients alike, individuals born with sickle cell trait (SCT) show no risk of experiencing the acute pain crises known to occur with sickle ...

Sickle cell conditions are genetic blood disorders that affect haemoglobin, the molecule in red blood cells responsible for carrying oxygen throughout the body. While both sickle cell trait and sickle ...

Sickle cell anemia can cause your blood cells to stick as they move through your body, leading to symptoms such as fatigue, intense pain, and jaundice. Symptoms such as chest pain may signal a sickle ...

Sickle cell anemia is the most severe form of sickle cell disease (SCD). Treatments for sickle cell anemia include medications, blood transfusions, and bone marrow transplants. SCD is a group of ...

People with sickle cell anemia, especially children, are more likely to experience a stroke. Silent strokes, which don’t cause noticeable symptoms, are especially common. Sickle cell anemia (SCA) is a ...

Sickle cell anemia is the most serious form of sickle cell disease (SCD). It occurs when a person inherits an irregular hemoglobin gene from each parent. Certain groups of people are more at risk of ...

A one-time gene-editing therapy, exagamglogene autotemcel (exa-cel), has demonstrated sustained and clinically meaningful ...

UdeM's Stéphanie Forté and co-researchers in Canada and Brazil have shown how people with sickle cell disease or sickle cell trait have a higher chance of dying from COVID-19 than the general ...

WASHINGTON -- Thousands of families carry the gene that causes sickle cell disease and don't know it -- even though almost every newborn today is tested for what's called "sickle cell trait," and ...

UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 ...